The HIV/AIDS Epidemic in the United States: The Basics

Key Facts

Box 1: Key Snapshot of the U.S. Epidemic Today
  • Number of new HIV infections: 38,500
  • Number of people living with HIV: 1.1+ million
  • Percent of people infected with HIV who don’t know it: 15%
  • Percent of people with HIV who are virally suppressed: 51%
Overview

Impact Across the Country

Table 1: Top Ten States/Areas by Number and Rate of New HIV Diagnoses (Adults and Adolescents), 2017
State New HIV Diagnoses, Number (%) State/Area New HIV Diagnoses, per 100,000
Florida 4,800 (12%) District of Columbia 46.3
California 4,500 (12%) Georgia 24.9
Texas 4,364 (11%) Florida 22.9
New York 2,772 (7%) Louisiana 22.1
Georgia 2,595 (7%) Maryland 17.0
North Carolina 1,315 (3%) Nevada 16.5
Illinois 1,265 (3%) Texas 15.4
New Jersey 1,109 (3%) Mississippi 14.3
Pennsylvania 1,094 (3%) South Carolina 14.3
Louisiana 1,033 (3%) New York 14.0
Subtotal 27,847 (72%)
U.S. Total 38,739 (100%) U.S. Rate 11.8
NOTES: Mississippi’s new HIV diagnosis rate for 2017 was 14.34, and South Carolina’s new HIV diagnosis rate for 2017 was 14.29. Table includes data on HIV diagnoses among adults and adolescents and reflects data from U.S. dependent areas.
SOURCE: CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

Impact on Racial and Ethnic Minorities

Figure 1: New HIV Diagnoses & U.S. Population, by Race/Ethnicity, 2017

Impact on Women

Impact on Young People

Impact on Gay and Bisexual Men

The U.S. Government Response

Endnotes
  1. CDC. MMWR, Vol. 30, No. 21; June 1981.

    ← Return to text

  2. CDC. Supplemental Surveillance Report. Estimated HIV Incidence and Prevalence in the United States 2010–2015. Vol 23. No. 1. 2018.

    ← Return to text

  3. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  4. CDC. HIV Surveillance Supplemental Report, Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data, Vol. 23, No. 4; June 2018.

    ← Return to text

  5. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  6. CDC. HIV Surveillance Supplemental Report, Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data, Vol. 23, No. 4; June 2018.

    ← Return to text

  7. CDC. Supplemental Surveillance Report. Estimated HIV Incidence and Prevalence in the United States 2010–2015. Vol 23. No. 1. 2018.

    ← Return to text

  8. DHHS. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV; updated October 2018.

    ← Return to text

  9. CDC. HIV Treatment as Prevention; updated November 2018.

    ← Return to text

  10. CDC. HIV Surveillance Supplemental Report, Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data, Vol. 23, No. 4; June 2018.

    ← Return to text

  11. CDC. HIV Surveillance Supplemental Report, Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data, Vol. 23, No. 4; June 2018.

    ← Return to text

  12. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  13. CDC. Supplemental Surveillance Report. Estimated HIV Incidence and Prevalence in the United States 2010–2015. Vol 23. No. 1. 2018.

    ← Return to text

  14. CDC. NCHS. Health, United States, 2017; September 2018.

    ← Return to text

  15. CDC. NCHS. Deaths: Leading Causes for 2016; November 2018.

    ← Return to text

  16. CDC. NCHS. Deaths: Leading Causes for 2016; November 2018.

    ← Return to text

  17. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  18. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  19. CDC. HIV Surveillance—Epidemiology of HIV Infection (through 2017); November 2018.

    ← Return to text

  20. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  21. CDC. HIV Surveillance—Epidemiology of HIV Infection (through 2017); November 2018.

    ← Return to text

  22. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  23. CDC. MMWR, Vol. 68, No. 11; March 2019.

    ← Return to text

  24. CDC. MMWR, Vol. 55, No. RR14; September 2006.

    ← Return to text

  25. KFF. HIV Testing in the United States; June 2018.

    ← Return to text

  26. DHHS. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents; updated October 2018.

    ← Return to text

  27. AIDSinfo, Statement by the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Regarding Results from the START and TEMPRANO Trials; July 2015.

    ← Return to text

  28. CDC. HIV Treatment as Prevention; updated November 2018.

    ← Return to text

  29. CDC. Supplemental Surveillance Report. Estimated HIV Incidence and Prevalence in the United States 2010–2015. Vol 23. No. 1. 2018.; CDC. Selected National HIV Prevention and Care Outcomes (2015, 2016).

    ← Return to text

  30. Bradley H et al. Increased HIV viral suppression among US adults receiving medical care, 2009-2013, Conference on Retroviruses and Opportunistic Infections (CROI), Boston, abstract 53; 2016.

    ← Return to text

  31. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  32. CDC. Atlas Plus. See: https://gis.cdc.gov/grasp/nchhstpatlas/main.html. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  33. U.S. Census Bureau. Quick Facts: 2017 Population Estimates. July 2017.

    ← Return to text

  34. CDC. Atlas Plus. See: https://gis.cdc.gov/grasp/nchhstpatlas/main.html. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  35. U.S. Census Bureau. Quick Facts: 2017 Population Estimates. July 2017.

    ← Return to text

  36. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  37. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  38. CDC. HIV Surveillance Supplemental Report, Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data, Vol. 23, No. 4; June 2018.

    ← Return to text

  39. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  40. KFF. State Health Facts; accessed December 2018.

    ← Return to text

  41. CDC. Supplemental Surveillance Report. Estimated HIV Incidence and Prevalence in the United States 2010–2015. Vol 23. No. 1. 2018.

    ← Return to text

  42. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  43. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  44. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  45. CDC. NCHS. Health, United States, 2016; September 2018.

    ← Return to text

  46. CDC. NCHS. Deaths: Leading Causes for 2016; July 2018.

    ← Return to text

  47. CDC. NCHS. Deaths: Leading Causes for 2016; July 2018.

    ← Return to text

  48. CDC. Supplemental Surveillance Report. Estimated HIV Incidence and Prevalence in the United States 2010–2015. Vol 23. No. 1. 2018.

    ← Return to text

  49. CDC. Supplemental Surveillance Report. Estimated HIV Incidence and Prevalence in the United States 2010–2015. Vol 23. No. 1. 2018.

    ← Return to text

  50. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  51. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  52. CDC. Slide Set: HIV Surveillance – Adolescents and Young Adults (through 2017).

    ← Return to text

  53. CDC. Slide Set: HIV Surveillance – Adolescents and Young Adults (through 2017).

    ← Return to text

  54. CDC. HIV Surveillance Supplemental Report, Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data, Vol. 23, No. 4; June 2018.

    ← Return to text

  55. Nesheim S et al. “A Framework for Elimination of Perinatal Transmission of HIV in the United States.” Pediatrics, Vol. 130, No. 4; September 2012.

    ← Return to text

  56. Whitmore SK et al. “Correlates of Mother-to-Child Transmission of HIV in the United States and Puerto Rico.” Pediatrics, Vol. 129, No. 1; January 2012.

    ← Return to text

  57. KFF. National Survey of Young Adults on HIV/AIDS; November 2017.

    ← Return to text

  58. KFF analysis of CDC data.

    ← Return to text

  59. CDC. HIV in the United States: At a Glance; December 2018.

    ← Return to text

  60. CDC. Supplemental Surveillance Report. Estimated HIV Incidence and Prevalence in the United States 2010–2015. Vol 23. No. 1. 2018.

    ← Return to text

  61. CDC. HIV Surveillance Supplemental Report, Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data, Vol. 23, No. 4; June 2018.

    ← Return to text

  62. CDC. Supplemental Surveillance Report. Estimated HIV Incidence and Prevalence in the United States 2010–2015. Vol 23. No. 1. 2018.

    ← Return to text

  63. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  64. CDC. Lifetime Risk of HIV Diagnosis; February 2016.

    ← Return to text

  65. CDC. HIV Surveillance Report, Diagnoses of HIV Infection in the United States and Dependent Areas, 2017, Vol. 29; November 2018. HIV diagnosis data are estimates from 50 states, the District of Columbia, and 6 U.S. dependent areas. Estimates for 2017 are preliminary and are not included in trend calculations.

    ← Return to text

  66. CDC. HIV Surveillance Special Report, HIV Infection Risk, Prevention, and Testing Behaviors among Men Who Have Sex With Men. National HIV Behavioral Surveillance, 20 U.S. Cities, 2014, No. 15; January 2016.

    ← Return to text

  67. CDC. HIV Surveillance Special Report, HIV Infection Risk, Prevention, and Testing Behaviors among Men Who Have Sex With Men. National HIV Behavioral Surveillance, 20 U.S. Cities, 2014, No. 15; January 2016.

    ← Return to text

  68. KFF. U.S. Federal Funding for HIV/AIDS: Trends Over Time; March 2019.

    ← Return to text

  69. Kates, J. and Dawson, L. Kaiser Family Foundation. Insurance Coverage Changes for People with HIV Under the ACA. 2017. Available at:  https://www.kff.org/health-reform/issue-brief/insurance-coverage-changes-for-people-with-hiv-under-the-aca/

    ← Return to text

  70. KFF. The Affordable Care Act, the Supreme Court, and HIV: What Are the Implications? September 2012.

    ← Return to text

  71. KFF. The ACA and People with HIV: An Update; May 2016.

    ← Return to text